For over 30 years, MedWorks Media has been bridging research and clinical practice as a psychiatric medical publisher.
This issue features systematic reviews on asenapine in bipolar disorder and naltrexone in alcohol use disorder, emerging research on suzetrigine and clavulanic acid for pain and cocaine use disorder, alongside review articles on antipsychotic risk-benefit profiles and Alzheimer’s pharmacotherapy, and case studies examining treatment-resistant schizophrenia, valproate-induced encephalopathy, and neuropsychiatric management in Fragile X syndrome.
Validated assessment tools for clinical research, pharmaceutical trials, and psychiatric practice. Our collection represents decades of rigorous validation trusted by leading research institutions worldwide.
The definitive clinical reference guide for evidence-based psychopharmacology. Authored by Stanford University experts, providing comprehensive dosing guidelines and monitoring protocols.
For over 30 years, MedWorks Media has earned the trust of healthcare professionals worldwide through rigorous editorial standards and prestigious academic partnerships. Our publications are indexed in the world’s most respected medical databases and backed by leading experts from Harvard, Stanford, Columbia, and other premier institutions.
Medical publisher specializing in peer-reviewed journals and clinical resources for healthcare professionals since 1994.
Psychopharmacology Bulletin (ISSN 2472-2448) is indexed in PubMed, SCOPUS, Science Citation Index, and other major medical databases.
© 2026 MedWorks Media Inc. | All Rights Reserved
